Niagen Bioscience

Niagen Bioscience is a California-based, NASDAQ-listed biotechnology company specializing in the research, development, and commercialization of NAD+ science and solutions.

We are dedicated to advancing healthy-aging science by pioneering the understanding and optimization of nicotinamide adenine dinucleotide (NAD+), a vital coenzyme that declines with age. Our team of world-renowned scientists collaborates with leading universities and research institutions globally to unlock the full potential of NAD+.

Niagen Bioscience is the innovator behind Niagen®, the most efficient and superior-quality NAD+ booster, backed by over 35 human clinical trials and 400+ peer-reviewed studies. We offer two distinct product lines: Tru Niagen®, the number one healthy-aging NAD+ supplement in the United States, and Niagen® Plus, our premium pharmaceutical-grade NAD+ therapy featuring Niagen® IV and injectables.

As pioneers in NAD+ technology, we continue to demonstrate our commitment to excellence, innovation, and integrity through our two California locations (Tustin and Westwood) and our premier research Laboratory & Innovation Center in Longmont, CO.